Success Metrics

Completion Rate
0%(0/1)
Active Trials
3(38%)
Terminated
1(13%)

Phase Distribution

Ph not_applicable
3
38%
Ph phase_2
4
50%
Ph early_phase_1
1
13%

Phase Distribution

1

Early Stage

4

Mid Stage

0

Late Stage

Phase Distribution8 total trials
Early Phase 1First-in-human
1(12.5%)
Phase 2Efficacy & side effects
4(50.0%)
N/ANon-phased studies
3(37.5%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

0.0%

0 of 2 finished

Non-Completion Rate

100.0%

2 ended early

Currently Active

3

trials recruiting

Total Trials

8

all time

Status Distribution
Active(3)
Terminated(2)
Other(3)

Detailed Status

unknown3
Recruiting2
Terminated1
Active, not recruiting1
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
8
Active
3
Success Rate
0.0%
Most Advanced
Phase 2

Trials by Phase

Early Phase 11 (12.5%)
Phase 24 (50.0%)
N/A3 (37.5%)

Trials by Status

recruiting225%
terminated113%
active_not_recruiting113%
unknown338%
withdrawn113%

Recent Activity

Clinical Trials (8)

Drug Details

Intervention Type
DIETARY SUPPLEMENT
Total Trials
8